Clover Health General Counsel Gia Lee steps down; Karen Soares named Interim GC

CLOVER HEALTH INVESTMENTS, CORP. /DE

Gia Lee, General Counsel, steps down effective Jan 19, 2022; Karen Soares named Interim General Counsel.
Lee receives separation payments: $520k (12 months base salary + prior year bonus), $120k (2021 bonus), $700k special cash bonus for de-SPAC work.
During 12-month consulting period, Lee gets $10k/month and continued stock option vesting; she may terminate consulting at any time.
Departure not due to any disagreement; CEO Vivek Garipalli thanked Lee for her contributions.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gia Lee

General Counsel

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2022-01-19
Successor: Karen Soares
Filed: January 19, 2022, 6:59 PM ET

Gia Lee, the Company’s General Counsel, will be stepping down as an officer of the Company today.

Appointed (interim)

Karen Soares

Interim General Counsel

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2022-01-19
Filed: January 19, 2022, 6:59 PM ET

Effective on January 19, 2022, and until a permanent replacement for Ms. Lee has been named, Karen Soares, the Company’s Deputy General Counsel, will serve as the Company’s Interim General Counsel.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gia Lee departed as General Counsel at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: stepping down
Role: General Counsel

Exact text from the filing

Gia Lee, the Company’s General Counsel, will be stepping down as an officer of the Company today.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Karen Soares was appointed as Interim General Counsel at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: appointed
Role: Interim General Counsel

Exact text from the filing

Effective on January 19, 2022, and until a permanent replacement for Ms. Lee has been named, Karen Soares, the Company’s Deputy General Counsel, will serve as the Company’s Interim General Counsel.

View on SEC.gov

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-22-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.